Metastatic GI Cancers
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers (NCT05205330) | Rottapharm Biotech | 2021-11-23 |
Track Metastatic GI Cancers automatically
Every clearance here is in the API, with alerts when new ones post.